Payment overview · 2025
General Payments
$339.65
13 reported records · 9 companies
Healthcare provider profile · identity verified
Casey Lawrence Stelter, MD
Allopathic & Osteopathic Physicians|Family Medicine · LAYTON, UT · NPI 1073607222
Verified facts
What the public records show
CMS Open Payments records show Casey Lawrence Stelter, MD received $339.65 in general payments during 2025 across 13 reported records.
ABBVIE INC. accounted for 25.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 12 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Arexvy, Qulipta.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 48 claims for Linzess by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported QULIPTA as an associated drug or biological on 298617 records involving 58957 distinct recipient NPIs. Public Medicare Part D data also shows 12 claims for Qulipta by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYNTHROID as an associated drug or biological on 10655 records involving 4881 distinct recipient NPIs. Public Medicare Part D data also shows 16 claims for Synthroid by this doctor in 2024.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 229 claims for Myrbetriq by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported AREXVY as an associated drug or biological on 47563 records involving 28786 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Arexvy by this doctor in 2024.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 39 claims for Trelegy Ellipta by this doctor in 2024.
Novartis Pharmaceuticals Corporation reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ENTRESTO as an associated drug or biological on 9346 records involving 6254 distinct recipient NPIs. Public Medicare Part D data also shows 53 claims for Entresto by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 1581 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $86.54 | 25.5% | 4 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $79.99 | 23.6% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $50.93 | 15.0% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $23.83 | 7.0% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $23.26 | 6.8% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $21.99 | 6.5% | 1 | 2025 |
| Novartis Pharmaceuticals Corporation | Unresolved — no canonical attribution shown | $19.41 | 5.7% | 1 | 2025 |
| Cranial Technologies, Inc | Unresolved — no canonical attribution shown | $18.68 | 5.5% | 1 | 2025 |
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $15.02 | 4.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $259.66 | 12 |
| Education | $79.99 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VRAYLAR Normalized: vraylar |
Drug | ABBVIE INC. | $58.75 | 3 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $50.93 | 2 | 2025 |
Source payment records
|
|||||
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $27.79 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $27.79 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $23.83 | 1 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE 3 Normalized: freestyle libre 3 |
Device | Abbott Laboratories | $23.26 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $21.99 | 1 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $21.99 | 1 | 2025 |
Source payment records
|
|||||
| LEQVIO Normalized: leqvio |
Drug | Novartis Pharmaceuticals Corporation | $19.41 | 1 | 2025 |
Source payment records
|
|||||
| Doc Band Normalized: doc band |
Device | Cranial Technologies, Inc | $18.68 | 1 | 2025 |
Source payment records
|
|||||
| AREXVY Normalized: arexvy |
Biological | GlaxoSmithKline, LLC. | $15.02 | 1 | 2025 |
Source payment records
|
|||||
| SHINGRIX Normalized: shingrix |
Biological | GlaxoSmithKline, LLC. | $15.02 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| AREXVY arexvy |
2025 | Arexvy | 2024 | 15 | exact normalized | Medicare Part D |
| QULIPTA qulipta |
2025 | Qulipta | 2024 | 12 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
48 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | QULIPTA open payments reported associated product |
CMS Open Payments — General Payments 298617 supporting records · 58957 recipient NPIs · example record 1201352530 |
Qulipta · 2024 Exact normalized brand match · 1 Part D row |
12 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | SYNTHROID open payments reported associated product |
CMS Open Payments — General Payments 10655 supporting records · 4881 recipient NPIs · example record 1201352636 |
Synthroid · 2024 Exact normalized brand match · 1 Part D row |
16 | suppressed by CMS |
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
229 | 22 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | AREXVY open payments reported associated product |
CMS Open Payments — General Payments 47563 supporting records · 28786 recipient NPIs · example record 1190332445 |
Arexvy · 2024 Exact normalized brand match · 1 Part D row |
15 | 15 |
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
39 | 14 |
| Novartis Pharmaceuticals Corporation Exact reporting entity; no affiliate inference |
2025 | ENTRESTO open payments reported associated product |
CMS Open Payments — General Payments 9346 supporting records · 6254 recipient NPIs · example record 1200004797 |
Entresto · 2024 Exact normalized brand match · 1 Part D row |
53 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
1581 | 147 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2373 | 316 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1835 | 208 |
| Eliquis | Apixaban | 1581 | 147 |
| Lisinopril | Lisinopril | 1363 | 198 |
| Potassium Chloride | Potassium Chloride | 1164 | 174 |
| Furosemide | Furosemide | 1101 | 182 |
| Trazodone Hcl | Trazodone Hcl | 1055 | 179 |
| Gabapentin | Gabapentin | 933 | 188 |
| Amlodipine Besylate | Amlodipine Besylate | 845 | 141 |
| Sertraline Hcl | Sertraline Hcl | 825 | 105 |
| Duloxetine Hcl | Duloxetine Hcl | 785 | 101 |
| Metformin Hcl | Metformin Hcl | 757 | 122 |
| Omeprazole | Omeprazole | 695 | 158 |
| Mirtazapine | Mirtazapine | 578 | 94 |
| Losartan Potassium | Losartan Potassium | 576 | 113 |
| Famotidine | Famotidine | 574 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 573 | 102 |
| Tradjenta | Linagliptin | 545 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 527 | 112 |
| Baclofen | Baclofen | 518 | 53 |
| Spironolactone | Spironolactone | 507 | 62 |
| Ondansetron Hcl | Ondansetron Hcl | 494 | 154 |
| Metoprolol Succinate | Metoprolol Succinate | 478 | 87 |
| Escitalopram Oxalate | Escitalopram Oxalate | 446 | 72 |
| Bumetanide | Bumetanide | 435 | 42 |
| Metformin Hcl Er | Metformin Hcl | 400 | 58 |
| Levetiracetam | Levetiracetam | 388 | 36 |
| Buspirone Hcl | Buspirone Hcl | 384 | 47 |
| Carvedilol | Carvedilol | 365 | 73 |
| Divalproex Sodium | Divalproex Sodium | 361 | 39 |
| Warfarin Sodium | Warfarin Sodium | 344 | 20 |
| Allopurinol | Allopurinol | 333 | 47 |
| Jardiance | Empagliflozin | 322 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 319 | 48 |
| Glipizide | Glipizide | 311 | 43 |
| Quetiapine Fumarate | Quetiapine Fumarate | 310 | 39 |
| Farxiga | Dapagliflozin Propanediol | 308 | 35 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 297 | 71 |
| Alendronate Sodium | Alendronate Sodium | 276 | 37 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 274 | 77 |
| Celecoxib | Celecoxib | 260 | 46 |
| Fluoxetine Hcl | Fluoxetine Hcl | 259 | 42 |
| Diclofenac Sodium | Diclofenac Sodium | 253 | 70 |
| Prednisone | Prednisone | 241 | 74 |
| Pioglitazone Hcl | Pioglitazone Hcl | 232 | 32 |
| Midodrine Hcl | Midodrine Hcl | 230 | 53 |
| Myrbetriq | Mirabegron | 229 | 22 |
| Meloxicam | Meloxicam | 228 | 33 |
| Fluconazole | Fluconazole | 216 | 109 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 209 | 42 |
| Cephalexin | Cephalexin | 197 | 93 |
| Torsemide | Torsemide | 197 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 193 | 34 |
| Bupropion Xl | Bupropion Hcl | 192 | 40 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 188 | 50 |
| Hydralazine Hcl | Hydralazine Hcl | 180 | 52 |
| Clopidogrel | Clopidogrel Bisulfate | 179 | 44 |
| Finasteride | Finasteride | 176 | 28 |
| Aripiprazole | Aripiprazole | 174 | 24 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 173 | 25 |
| Sevelamer Carbonate | Sevelamer Carbonate | 171 | 21 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 170 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 169 | 31 |
| Alprazolam | Alprazolam | 166 | 43 |
| Ceftriaxone | Ceftriaxone Sodium | 165 | 87 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 162 | 49 |
| Olanzapine | Olanzapine | 159 | 17 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 158 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 157 | 27 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 153 | 29 |
| Nystatin | Nystatin | 150 | 86 |
| Memantine Hcl | Memantine Hcl | 149 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 149 | 96 |
| Latanoprost | Latanoprost | 148 | 21 |
| Risperidone | Risperidone | 148 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 146 | 85 |
| Fluticasone Propionate | Fluticasone Propionate | 145 | 60 |
| Clonidine Hcl | Clonidine Hcl | 141 | 34 |
| Topiramate | Topiramate | 138 | 16 |
| Amiodarone Hcl | Amiodarone Hcl | 137 | 24 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 137 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 136 | 21 |
| Lamotrigine | Lamotrigine | 135 | 20 |
| Valsartan | Valsartan | 135 | 26 |
| Montelukast Sodium | Montelukast Sodium | 130 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 129 | 27 |
| Xarelto | Rivaroxaban | 129 | 23 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 128 | 75 |
| Hydrochlorothiazide | Hydrochlorothiazide | 128 | 36 |
| Ibuprofen | Ibuprofen | 128 | 48 |
| Lidocaine Hcl | Lidocaine Hcl | 127 | 73 |
| Clonazepam | Clonazepam | 126 | 24 |
| Divalproex Sodium Er | Divalproex Sodium | 119 | 13 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 119 | 24 |
| Glipizide Er | Glipizide | 117 | 14 |
| Simvastatin | Simvastatin | 113 | 30 |
| Donepezil Hcl | Donepezil Hcl | 111 | 22 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 108 | 21 |
| Calcium Acetate | Calcium Acetate | 104 | 11 |
| Doxycycline Hyclate | Doxycycline Hyclate | 102 | 51 |
| Trulicity | Dulaglutide | 101 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 100 | 22 |
| Primidone | Primidone | 99 | 11 |
| Januvia | Sitagliptin Phosphate | 98 | 11 |
| Sucralfate | Sucralfate | 97 | 26 |
| Levofloxacin | Levofloxacin | 96 | 72 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 94 | 63 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 93 | 11 |
| Propranolol Hcl | Propranolol Hcl | 93 | 19 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 90 | 55 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 90 | 53 |
| Metoclopramide Hcl | Metoclopramide Hcl | 89 | 14 |
| Tramadol Hcl | Tramadol Hcl | 89 | 37 |
| Amitriptyline Hcl | Amitriptyline Hcl | 86 | 22 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 85 | suppressed |
| Azithromycin | Azithromycin | 83 | 52 |
| Benztropine Mesylate | Benztropine Mesylate | 80 | suppressed |
| Mupirocin | Mupirocin | 78 | 50 |
| Oxybutynin Chloride | Oxybutynin Chloride | 78 | 15 |
| Sumatriptan Succinate | Sumatriptan Succinate | 78 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 78 | 16 |
| Fenofibrate | Fenofibrate Nanocrystallized | 77 | 12 |
| Amoxicillin | Amoxicillin | 76 | 62 |
| Ondansetron Odt | Ondansetron | 75 | 39 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 74 | 24 |
| Meropenem | Meropenem | 73 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 73 | 14 |
| Buprenorphine Hcl | Buprenorphine Hcl | 71 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 70 | suppressed |
| Carbamazepine | Carbamazepine | 68 | suppressed |
| Hydrocortisone | Hydrocortisone | 64 | 26 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 63 | 34 |
| Loperamide | Loperamide Hcl | 63 | 33 |
| Diazepam | Diazepam | 62 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 62 | 15 |
| Metolazone | Metolazone | 61 | 11 |
| Scopolamine | Scopolamine | 61 | 16 |
| Bupropion Hcl | Bupropion Hcl | 60 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 59 | 29 |
| Austedo | Deutetrabenazine | 53 | suppressed |
| Entresto | Sacubitril/Valsartan | 53 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 53 | 25 |
| Ventolin Hfa | Albuterol Sulfate | 53 | 21 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 52 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 52 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 51 | 11 |
| Lactulose | Lactulose | 50 | 16 |
| Ipratropium Bromide | Ipratropium Bromide | 48 | suppressed |
| Lactated Ringers | Ringer's Solution,lactated | 48 | 23 |
| Linzess | Linaclotide | 48 | suppressed |
| Methocarbamol | Methocarbamol | 48 | 11 |
| Digoxin | Digoxin | 47 | suppressed |
| Acetic Acid | Acetic Acid | 46 | 20 |
| Asenapine Maleate | Asenapine Maleate | 46 | suppressed |
| Ezetimibe | Ezetimibe | 45 | suppressed |
| Movantik | Naloxegol Oxalate | 45 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 44 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 44 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 43 | suppressed |
| Nyamyc | Nystatin | 42 | 30 |
| Clotrimazole | Clotrimazole | 41 | 30 |
| Promethazine Hcl | Promethazine Hcl | 41 | 20 |
| Xifaxan | Rifaximin | 41 | suppressed |
| Mounjaro | Tirzepatide | 40 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 39 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 39 | 14 |
| Pregabalin | Pregabalin | 38 | 16 |
| Lokelma | Sodium Zirconium Cyclosilicate | 35 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 35 | suppressed |
| Novolog Flexpen | Insulin Aspart | 34 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 34 | suppressed |
| Ozempic | Semaglutide | 33 | suppressed |
| Renvela | Sevelamer Carbonate | 33 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 32 | suppressed |
| Enulose | Lactulose | 32 | 13 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 32 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 32 | 24 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 31 | 22 |
| Liothyronine Sodium | Liothyronine Sodium | 31 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 31 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 31 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 31 | suppressed |
| Budesonide | Budesonide | 30 | suppressed |
| Colchicine | Colchicine | 30 | suppressed |
| Creon | Lipase/Protease/Amylase | 30 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 30 | 14 |
| Megestrol Acetate | Megestrol Acetate | 30 | suppressed |
| Austedo Xr | Deutetrabenazine | 29 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 29 | 14 |
| Ziprasidone Hcl | Ziprasidone Hcl | 29 | suppressed |
| Amantadine | Amantadine Hcl | 28 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 28 | suppressed |
| Atenolol | Atenolol | 28 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 28 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 28 | suppressed |
| Insulin Lispro | Insulin Lispro | 28 | 17 |
| Anastrozole | Anastrozole | 27 | suppressed |
| Dalfampridine Er | Dalfampridine | 27 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 27 | suppressed |
| Estradiol | Estradiol | 27 | suppressed |
| Exemestane | Exemestane | 27 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 27 | 18 |
| Zonisamide | Zonisamide | 27 | suppressed |
| Auryxia | Ferric Citrate | 26 | suppressed |
| Lorazepam | Lorazepam | 26 | 13 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 25 | suppressed |
| Imatinib Mesylate | Imatinib Mesylate | 25 | suppressed |
| Linezolid | Linezolid | 25 | 15 |
| Nitroglycerin | Nitroglycerin | 25 | 17 |
| Tacrolimus | Tacrolimus | 25 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 25 | 15 |
| Verapamil Er | Verapamil Hcl | 25 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 24 | suppressed |
| Carisoprodol | Carisoprodol | 24 | suppressed |
| Chlorthalidone | Chlorthalidone | 24 | suppressed |
| Clozapine | Clozapine | 24 | suppressed |
| Glimepiride | Glimepiride | 24 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 24 | 12 |
| Metronidazole | Metronidazole | 24 | 20 |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 24 | suppressed |
| Calcitriol | Calcitriol | 23 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 23 | suppressed |
| Clonidine | Clonidine | 23 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 23 | suppressed |
| Ranolazine Er | Ranolazine | 23 | suppressed |
| Admelog | Insulin Lispro | 22 | suppressed |
| Daptomycin | Daptomycin | 22 | suppressed |
| Lansoprazole | Lansoprazole | 22 | suppressed |
| Sotalol | Sotalol Hcl | 22 | suppressed |
| Trospium Chloride | Trospium Chloride | 22 | suppressed |
| Clozapine Odt | Clozapine | 21 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 21 | suppressed |
| Acarbose | Acarbose | 20 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 20 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 20 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 20 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 20 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 19 | suppressed |
| Ursodiol | Ursodiol | 19 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 19 | suppressed |
| Carbamazepine Er | Carbamazepine | 18 | suppressed |
| Fanapt | Iloperidone | 18 | suppressed |
| Methimazole | Methimazole | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Admelog Solostar | Insulin Lispro | 17 | suppressed |
| Ertapenem | Ertapenem Sodium | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Methylprednisolone Acetate | Methylprednisolone Acetate | 17 | 11 |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Novolog | Insulin Aspart | 17 | 11 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 17 | suppressed |
| Restasis | Cyclosporine | 17 | suppressed |
| Tobramycin | Tobramycin | 17 | 15 |
| Cefdinir | Cefdinir | 16 | 14 |
| Dexlansoprazole Dr | Dexlansoprazole | 16 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 16 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 16 | suppressed |
| Vascepa | Icosapent Ethyl | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 15 | 15 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 15 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 15 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 15 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 15 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 15 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 15 | suppressed |
| Azathioprine | Azathioprine | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Humalog | Insulin Lispro | 14 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 14 | suppressed |
| Ketoconazole | Ketoconazole | 14 | suppressed |
| Lunesta | Eszopiclone | 14 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 14 | suppressed |
| Paliperidone Er | Paliperidone | 14 | suppressed |
| Phenytoin | Phenytoin | 14 | suppressed |
| Rasagiline Mesylate | Rasagiline Mesylate | 14 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 14 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 14 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 14 | suppressed |
| Dextroamphetamine Sulfate | Dextroamphetamine Sulfate | 13 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 13 | 12 |
| Lidocaine-Prilocaine | Lidocaine/Prilocaine | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | 11 |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 13 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 12 | suppressed |
| Armodafinil | Armodafinil | 12 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 12 | suppressed |
| Eszopiclone | Eszopiclone | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 12 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 12 | suppressed |
| Qulipta | Atogepant | 12 | suppressed |
| Roflumilast | Roflumilast | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Trimethoprim | Trimethoprim | 12 | suppressed |
| Acyclovir | Acyclovir | 11 | suppressed |
| Carvedilol Er | Carvedilol Phosphate | 11 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Lidocaine | Lidocaine | 11 | suppressed |
| Neomycin-Polymyxin-Hydrocort | Neomycin/Polymyxin B/Hydrocort | 11 | suppressed |
| Potassium Citrate Er | Potassium Citrate | 11 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 11 | suppressed |
| Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 11 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 11 | suppressed |
| Velphoro | Sucroferric Oxyhydroxide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $339.65 · 13 records | ABBVIE INC. | AREXVY, Doc Band, EVENITY, FREESTYLE LIBRE 3, LEQVIO, NURTEC ODT, QULIPTA, SHINGRIX, UBRELVY, VRAYLAR, WATCHMAN Access System, ZAVZPRET | 9 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Arexvy play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error